Literature DB >> 823173

Effect of vaccination schedule on immune response of Macaca mulatta to cell culture-grown Rocky Mountain spotted fever vaccine.

L S Sammons, R H Kenyon, C E Pedersen.   

Abstract

The effect of vaccination schedule on the immune response of Macaca mulatta to formalin-inactivated chicken embryo cell culture (CEC)-grown Rickettsia rickettsii vaccine was studied. Schedules consisted of inoculation on day 1 only, on days 1 and 15, on days 1 and 30, on days 1, 8, and 15, or on days 1, 15, and 45. Humoral antibody measured by microagglutination and indirect immunofluorescence and resistance to challenge with 10(4) plaque-forming units of yolk sac-grown R. rickettsii were assessed. Seroconversion was noted in all monkeys after the first dose of vaccine. A second dose administered 8 or 15 days after the primary infection, or a third given 7 or 30 days after the second, produced no long-term effect on antibody titer. Only monkeys given two doses of vaccine at a 30-day interval showed an increase in antibody titer during the period before challenge. Vaccination with one, two, or three doses of CEC vaccine prevented development of rash and rickettsemia after challenge. The two-dose schedules appeared to induce the highest degree of resistance to challenge, as indicated by unaltered hematological parameters and body temperature in monkeys. The one- and three-dose schedules were somewhat less effective, in that some challenged monkeys within each group displayed febrile and leukocyte responses associated with Rocky Mountain spotted fever infection. Our data suggest that administration of two doses of CEC vaccine at 15- or 30-day intervals is the immunization schedule of choice.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 823173      PMCID: PMC274446          DOI: 10.1128/jcm.4.3.253-257.1976

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Factors affecting the growth of rickettsias of the spotted fever group in fertile hens' eggs.

Authors:  H G STOENNER; D B LACKMAN; E J BELL
Journal:  J Infect Dis       Date:  1962 Mar-Apr       Impact factor: 5.226

2.  A microagglutination technique for detection and measurement of rickettsial antibodies.

Authors:  P Fiset; R A Ormsbee; R Silberman; M Peacock; S H Spielman
Journal:  Acta Virol       Date:  1969-01       Impact factor: 1.162

3.  Plaque assay for Rickettsia rickettsii.

Authors:  E H Weinberg; J R Stakebake; P J Gerone
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

4.  Changes in blood serum constituents and hematologic values in Macaca mulatta with Rocky Mountain spotted fever.

Authors:  L S Sammons; R H Kenyon; G T Burger; C E Pedersen; R O Spertzel
Journal:  Am J Vet Res       Date:  1976-06       Impact factor: 1.156

5.  Antibody response to Rocky Mountain spotted fever.

Authors:  R H Kenyon; P G Canonico; L S Sammons; L R Bagley; C E Pedersen
Journal:  J Clin Microbiol       Date:  1976-05       Impact factor: 5.948

6.  Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization.

Authors:  R H Kenyon; C E Pedersen
Journal:  J Clin Microbiol       Date:  1975-06       Impact factor: 5.948

7.  Comparison of three rocky mountain spotted fever vaccines.

Authors:  R H Kenyon; L S Sammons; C E Pedersen
Journal:  J Clin Microbiol       Date:  1975-10       Impact factor: 5.948

8.  Plaque formation in tissue cultures by Rickettsia rickettsi isolated directly from whole blood and tick hemolymph.

Authors:  D A Wike; W Burgdorfer
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

  8 in total
  2 in total

1.  Exposure of guinea pigs to Rickettsia rickettsii by aerosol, nasal, conjunctival, gastric, and subcutaneous routes and protection afforded by an experimental vaccine.

Authors:  R H Kenyon; R A Kishimoto; W C Hall
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

2.  Evaluation of a killed Rocky Mountain spotted fever vaccine in cynomolgus monkeys.

Authors:  J C Gonder; R H Kenyon; C E Pedersen
Journal:  J Clin Microbiol       Date:  1979-11       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.